Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Spine (Phila Pa 1976). 2012 Jan 15;37(2):140–149. doi: 10.1097/BRS.0b013e3182276b2b

Table 1.

Area under curve subgroup results for Oswestry Disability Index (ODI) change scores, adjusted for age, gender, center, and baseline ODI score (Time weighted average 4 years treatment effects).

N Surgical
(n = 788)
Non-operative
(n = 404)
Treatment Effect(95% CI)

Baseline ODI ≤ 31 258 −21.4 (1.5) −5.2 (1.2) −16.1 (−19.1, −13.1)
31 < Baseline ODI ≤ 45 252 −29.4 (1.3) −14.9 (1.4) −14.5 (−17.5, −11.4)
45 < Baseline ODI ≤ 60 293 −39.2 (1.1) −23.1 (1.6) −16 (−19.3, −12.8)
Baseline ODI > 60 386 −50.8 (1) −39.1 (1.6) −11.7 (−14.9, −8.4)

     p-value <0.001 <0.001 0.18

Sciatica Bothersomeness ≤ 16 625 −37.3 (0.8) −25.4 (0.9) −11.9 (−13.7, −10)
Sciatica Bothersomeness > 16 556 −33.7 (0.8) −21.5 (1.1) −12.2 (−14.5, −10)

     p-value 0.001 0.006 0.82

Age <= 41 644 −35.6 (0.7) −25 (1) −10.6 (−12.6, −8.6)
Age > 41 548 −35.7 (0.8) −22.5 (0.9) −13.3 (−15.3, −11.2)

     p-value 0.89 0.06 0.06

Female 507 −35 (0.8) −22.3 (1) −12.7 (−14.9, −10.5)
Male 685 −36.1 (0.7) −24.7 (0.9) −11.4 (−13.2, −9.5)

     p-value 0.31 0.068 0.35

Body Mass Index < 30 854 −38.1 (0.6) −25.6 (0.8) −12.4 (−14.1, −10.7)
Body Mass Index ≤30 336 −29.9 (1) −18.1 (1.3) −11.9 (−14.5, −9.2)

     p-value <0.001 <0.001 0.71

Reflex Asymmetry 481 −36 (0.8) −25.1 (1.1) −10.9 (−13.1, −8.6)
No Reflex Asymmetry 710 −35.4 (0.7) −22.8 (0.9) −12.6 (−14.4, −10.7)

     p-value 0.60 0.095 0.24

Positive Straight Leg Raise 970 −35.8 (0.6) −24.2 (0.8) −11.6 (−13.2, −10)
Negative Straight Leg Raise 221 −34.4 (1.4) −22.9 (1.4) −11.4 (−14.7, −8.2)

     p-value 0.35 0.42 0.93

No Joint Problem 963 −37.1 (0.6) −24.5 (0.8) −12.6 (−14.2, −11)
Joint Problem 221 −28.2 (1.3) −20 (1.4) −8.2 (−11.3, −5.1)

     p-value <0.001 0.005 0.01

Not Depressed 1044 −36.5 (0.6) −24.5 (0.7) −12 (−13.5, −10.4)
Depressed 141 −28.9 (1.6) −16.4 (1.9) −12.5 (−16.4, −8.5)

     p-value <0.001 <0.001 0.82

No Other Comorbidities** 666 −38.1 (0.7) −25.8 (0.9) −12.3 (−14.2, −10.4)
Other Comorbidities 526 −32.3 (0.8) −21.2 (1) −11.2 (−13.2, −9.1)

     p-value <0.001 <0.001 0.41

No Missed Work 318 −37.9 (1) −26.9 (1.3) −11 (−13.7, −8.4)
Missed Work 724 −34.8 (0.7) −23.7 (0.9) −11.1 (−13, −9.3)

     p-value 0.015 0.04 0.96

No Opiod Use 520 −38.6 (0.9) −27 (1) −11.6 (−13.7, −9.5)
Opiod Use 542 −34.8 (0.8) −22.8 (1.1) −12 (−14.3, −9.8)

     p-value 0.001 0.005 0.80

No Prior Injections 625 −37.7 (0.8) −25.7 (0.9) −12 (−13.9, −10.1)
Prior Injections 567 −33.5 (0.8) −21.3 (1) −12.2 (−14.3, −10)

     p-value <0.001 0.001 0.91

No Insurance 38 −20.1 (3.1) −13.1 (4.7) −7 (−16.9, 2.9)
Insured 1151 −36.1 (0.5) −24.1 (0.7) −12 (−13.4, −10.5)

     p-value <0.001 0.019 0.33

No Litigation 1110 −36.9 (0.5) −24.9 (0.7) −11.9 (−13.4, −10.4)
Litigation Pending/Resolved 81 −17.4 (2) −7.7 (2.7) −9.7 (−15, −4.4)

     p-value <0.001 <0.001 0.42

Dissatisfied with Symptoms 1134 −35.7 (0.6) −23.7 (0.7) −12 (−13.5, −10.5)
Satisfied with Symptoms or Neutral 57 −33.4 (2.9) −24.7 (2.6) −8.7 (−14.8, −2.6)

     p-value 0.44 0.69 0.30

Predominant back pain 221 −31.9 (1.3) −21.8 (1.4) −10.1 (−13.1, −7.1)
Predominant leg pain 962 −36.4 (0.6) −24 (0.8) −12.4 (−14, −10.8)

     p-value 0.002 0.18 0.18

High school education or less 287 −32.2 (1.1) −16.1 (1.4) −16.1 (−19, −13.2)
At least some college or more 884 −36.8 (0.6) −26.1 (0.8) −10.7 (−12.3, −9)

     p-value <0.001 <0.001 0.001

Sensory Deficit 603 −34.6 (0.7) −22.3 (1) −12.3 (−14.3, −10.3)
Sensory Intact 588 −36.8 (0.8) −24.9 (0.9) −11.9 (−13.9, −9.9)

     p-value 0.046 0.055 0.78

Motor Deficit 501 −35.3 (0.8) −23.8 (1.1) −11.5 (−13.8, −9.2)
Motor Intact 690 −35.9 (0.7) −23.8 (0.9) −12.2 (−14, −10.4)

     p-value 0.56 1 0.66

Other Herniation Location 272 −32 (1.2) −21.6 (1.3) −10.4 (−13.3, −7.4)
Posterolateral Herniation 919 −36.6 (0.6) −24.5 (0.8) −12.1 (−13.7, −10.4)

     p-value <0.001 0.055 0.31

No Stomach Problem 1042 −36.5 (0.6) −24.4 (0.7) −12.2 (−13.7, −10.6)
Stomach Problem 142 −28 (1.6) −17.3 (1.9) −10.7 (−14.6, −6.7)

     p-value <0.001 <0.001 0.49

No Hypertension 1022 −36 (0.6) −24.1 (0.7) −11.9 (−13.5, −10.3)
Hypertension 163 −33.4 (1.5) −20.3 (1.7) −13.1 (−16.6, −9.5)

     p-value 0.11 0.042 0.55

No Antidepressants Use 1011 −37.3 (0.6) −25.6 (0.7) −11.8 (−13.3, −10.2)
Taking Antidepressants 51 −22.1 (2.6) −14.1 (3.6) −8 (−15.3, −0.7)

     p-value <0.001 0.002 0.32

No NSAID Use 578 −36 (0.8) −24.9 (1) −11.1 (−13.3, −9)
Taking NSAID 484 −37.4 (0.9) −25.3 (1) −12.1 (−14.3, −9.9)

     p-value 0.23 0.78 0.52

No Physical Therapy 314 −37.6 (1.1) −24.7 (1.2) −12.9 (−15.6, −10.2)
Had Physical Therapy 878 −35 (0.6) −23.4 (0.8) −11.6 (−13.3, −9.9)

     p-value 0.036 0.35 0.42

No Lifting at Work 497 −39.7 (0.8) −27.7 (1) −12 (−14.2, −9.8)
Lifting at Work 694 −32.8 (0.7) −20.6 (0.9) −12.2 (−14.1, −10.3)

     p-value <0.001 <0.001 0.89

Worker's Compensation 208 −27.2 (1.2) −18.2 (1.8) −9 (−12.5, −5.5)
No Worker's Compensation 981 −37.5 (0.6) −24.9 (0.7) −12.6 (−14.2, −11)

     p-value <0.001 <0.001 0.06

L2-L3 / L3-4 Herniation 88 −32.7 (2.3) −22.7 (2.2) −10.1 (−15.6, −4.5)
L4-L5 Herniation 456 −36.8 (0.9) −23.7 (1.1) −13 (−15.3, −10.8)
L5-S1 Herniation 647 −35.1 (0.7) −24.2 (0.9) −10.9 (−12.8, −8.9)

     p-value 0.14 0.80 0.30

Protruding Herniation 322 −34.3 (1) −21.6 (1.2) −12.8 (−15.3, −10.3)
Extruded Herniation 783 −35.5 (0.7) −24.6 (0.9) −11 (−12.8, −9.1)
Sequestered Herniation 86 −41.9 (2.1) −25.6 (2.4) −16.4 (−21.6, −11.2)

     p-value 0.004 0.084 0.11

6 Weeks or Less Duration 165 −40.6 (1.5) −30.7 (1.7) −9.9 (−13.6, −6.2)
1.5 to 6 Months Duration 765 −36.3 (0.7) −24.8 (0.8) −11.5 (−13.2, −9.7)
More than 6 Months Duration 262 −30.5 (1.1) −15.8 (1.4) −14.7 (−17.7, −11.7)

     p-value <0.001 <0.001 0.09

Non-Smoker 607 −37.8 (0.8) −25.7 (0.9) −12.2 (−14.1, −10.2)
Ex-Smoker 298 −35.1 (1.1) −24.1 (1.3) −11.1 (−13.8, −8.3)
Smoker 282 −31.2 (1.1) −17.9 (1.4) −13.3 (−16.3, −10.3)

     p-value <0.001 <0.001 0.57

White 1033 −36.2 (0.6) −24.9 (0.7) −11.4 (−12.9, −9.8)
Black 75 −28 (2.5) −12.8 (2.4) −15.2 (−21, −9.4)
Other Race 84 −34.1 (2) −21 (2.6) −13.1 (−18.4, −7.8)

     p-value 0.004 <0.001 0.40

Married 835 −36.9 (0.6) −22.7 (0.8) −14.2 (−15.9, −12.5)
Divorced/Widowed 130 −29.1 (1.6) −18.9 (2.1) −10.3 (−14.5, −6)
Single 212 −35.4 (1.4) −30.1 (1.6) −5.2 (−8.5, −2)

     p-value <0.001 <0.001 <0.001

Not working 206 −33.5 (1.3) −18.8 (1.5) −14.7 (−18, −11.4)
Income Over $50,000 446 −38.7 (0.9) −28.3 (1.1) −10.4 (−12.8, −8.1)
Income Under $50,000 535 −34 (0.8) −22.2 (1) −11.9 (−14, −9.8)

     p-value <0.001 <0.001 0.11

Problem getting better 179 −42.3 (1.6) −29.8 (1.4) −12.4 (−15.8, −9.1)
Problem staying about the same 534 −35.8 (0.8) −25.1 (1) −10.7 (−12.8, −8.6)
Problem getting worse 472 −32.9 (0.8) −17.5 (1.3) −15.4 (−18, −12.9)

     p-value <0.001 <0.001 0.02

Baseline MCS <= 35 263 −30.2 (1.2) −16.4 (1.4) −13.9 (−16.9, −10.8)
Baseline MCS > 35 927 −37 (0.6) −26 (0.8) −11 (−12.6, −9.4)

     p-value <0.001 <0.001 0.10

Treatment effect is the difference between the surgical and non−operative mean change from baseline.

**

Other comorbidities include: stroke, diabetes, osteoporosis, cancer, fibromyalgia, cerebrospinal fluid leak, PTSD, alcohol, drug dependency, heart, lung, liver, kidney, blood vessel, nervous system, hypertension, migraine, anxiety, stomach, or bowel problems.